Skip to main content
Log in

Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases

  • Original Article
  • Published:
International Journal of Legal Medicine Aims and scope Submit manuscript

Abstract

The aim of this investigation was to identify pathogenic variants of the ryanodine receptor 2 (RYR2) gene in a cohort of persons aged 0–40 years who died of sudden unexpected death syndrome (SUD), including a cohort of infants who died of sudden infant death syndrome (SIDS). We genetically screened 29 of the 105 exons of the RYR2 gene associated with catecholaminergic polymorphic ventricular tachycardia (CPVT) in 74 cases of SUD without reported structural abnormalities of the heart. Cases were selected from the case database at the Institute of Forensic Medicine, and subsequent mutational screening by DNA sequencing was performed to detect variants in DNA samples extracted from blood samples of deceased persons. A total of 7 of the examined 74 cases were heterozygous for a rare sequence variant in the RYR2 gene. We identified five novel missense variants (p.Q486H, p.D1872N, p.G2367R, p.E4213D, and p.H4579Y), one synonymous variant (p.L4767L), and one previously reported missense variant (p.G4315E). Follow-up studies were possible in family members of three probands (p.Q486H, p.D1872N, and p.H4579Y), and clinical examinations were conducted in family members of two of these probands (p.Q486H and p.H4579Y). In conclusion, we identified a higher prevalence of variants in the CPVT-associated gene RYR2 than in a previously reported cohort of SIDS (9.4% vs. 1–2%). Segregation studies show that one variant (p.H4579Y) co-segregates with CPVT and is presumed to be pathogenic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tester DJ, Ackerman MJ (2006) The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 21(3):166–172

    Article  PubMed  Google Scholar 

  2. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ (2004) Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner’s cases. Mayo Clin Proc 79(11):1380–1384

    Article  PubMed  CAS  Google Scholar 

  3. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P (1995) Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91(5):1512–1519

    Article  PubMed  CAS  Google Scholar 

  4. Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K et al (1999) Arrhythmic disorder mapped to chromosome 1q42–q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 34(7):2035–2042

    Article  PubMed  CAS  Google Scholar 

  5. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M et al (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106(1):69–74

    Article  PubMed  CAS  Google Scholar 

  6. Tester DJ, Dura M, Carturan E, Reiken S, Wronska A, Marks AR et al (2007) A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors. Hear Rhythm 4(6):733–739

    Article  Google Scholar 

  7. Creighton W, Virmani R, Kutys R, Burke A (2006) Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. J Mol Diagn 8(1):62–67

    Article  PubMed  CAS  Google Scholar 

  8. Tester DJ, Kopplin LJ, Will ML, Ackerman MJ (2005) Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Hear Rhythm 2(10):1099–1105

    Article  Google Scholar 

  9. Allouis M, Probst V, Jaafar P, Schott JJ, Le MH (2005) Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation. Am J Cardiol 95(5):700–702

    Article  PubMed  CAS  Google Scholar 

  10. Liu N, Ruan Y, Priori SG (2008) Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis 51(1):23–30

    Article  PubMed  Google Scholar 

  11. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R et al (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103(2):196–200

    Article  PubMed  CAS  Google Scholar 

  12. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B et al (2001) Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103(4):485–490

    Article  PubMed  CAS  Google Scholar 

  13. Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O et al (2001) A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 69(6):1378–1384

    Article  PubMed  CAS  Google Scholar 

  14. Zalk R, Lehnart SE, Marks AR (2007) Modulation of the ryanodine receptor and intracellular calcium. Annu Rev Biochem 76:367–385

    Article  PubMed  CAS  Google Scholar 

  15. Wehrens XH, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ et al (2003) FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113(7):829–840

    Article  PubMed  CAS  Google Scholar 

  16. Berge KE, Haugaa KH, Fruh A, Anfinsen OG, Gjesdal K, Siem G et al (2008) Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers. Scand J Clin Lab Invest 68(5):362–368

    Article  PubMed  CAS  Google Scholar 

  17. Luderer R, Verheul A, Kortlandt W (2004) Rapid detection of the factor V Leiden mutation by real-time PCR with TaqMan minor groove binder probes. Clin Chem 50(4):787–788

    Article  PubMed  CAS  Google Scholar 

  18. Gregersen M, Rajs J, Laursen H et al (1995) Pathologic criteria for the Nordic study. In: Rognum TO, SIDS International Conference, Stavanger Norway, eds. Sudden Infant Death Syndrome: New Trends in the Nineties. Oslo: Scandinavian University Press, pp 50–58

  19. Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP et al (2009) The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J Am Coll Cardiol 54(22):2065–2074

    Article  PubMed  CAS  Google Scholar 

  20. Nishio H, Suzuki K (2009) Postmortem molecular analysis for fatal arrhythmogenic disease in sudden unexplained death. Leg Med (Tokyo) 11(Suppl 1):S119–S120

    Article  Google Scholar 

  21. Meli AC, Refaat MM, Dura M, Reiken S, Wronska A, Wojciak J et al (2011) A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium. Circ Res 109(3):281–290

    Article  PubMed  CAS  Google Scholar 

  22. Jiang D, Jones PP, Davis DR, Gow R, Green MS, Birnie DH et al (2010) Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia. Channels (Austin) 4(4):302–310

    Article  CAS  Google Scholar 

  23. Carturan E, Tester DJ, Brost BC, Basso C, Thiene G, Ackerman MJ (2008) Postmortem genetic testing for conventional autopsy-negative sudden unexplained death: an evaluation of different DNA extraction protocols and the feasibility of mutational analysis from archival paraffin-embedded heart tissue. Am J Clin Pathol 129(3):391–397

    Article  PubMed  CAS  Google Scholar 

  24. Michaud K, Mangin P, Elger BS (2011) Genetic analysis of sudden cardiac death victims: a survey of current forensic autopsy practices. Int J Legal Med 125(3):359–366

    Article  PubMed  Google Scholar 

  25. Yano M, Yamamoto T, Ikeda Y, Matsuzaki M (2006) Mechanisms of disease: ryanodine receptor defects in heart failure and fatal arrhythmia. Nat Clin Pract Cardiovasc Med 3(1):43–52

    Article  PubMed  CAS  Google Scholar 

  26. Brion M, Quintela I, Sobrino B, Torres M, Allegue C, Carracedo A (2010) New technologies in the genetic approach to sudden cardiac death in the young. Forensic Sci Int 203(1–3):15–24

    Article  PubMed  CAS  Google Scholar 

  27. Wong CH, Koo SH, She GQ, Chui P, Lee EJ (2009) Genetic variability of RyR2 and CASQ2 genes in an Asian population. Forensic Sci Int 192(1–3):53–55

    Article  PubMed  CAS  Google Scholar 

  28. Roux-Buisson N, Rendu J, Denjoy I, Guicheney P, Goldenberg A, David N et al (2011) Functional analysis reveals splicing mutations of the CASQ2 gene in patients with CPVT: implication for genetic counselling and clinical management. Hum Mutat. doi:10.1002/humu.21537

Download references

Acknowledgment

This work was supported by research grants from the Jørgen Møllers Foundation, the Augustinus Foundation, the Grosserer A. V. Lykfeldt and Wife Foundation, the Helga and Peter Kornings Foundation, the Grosserer Valdemar Foersom and Thyra Foersom Foundation, and Aarhus University.

Ethical standards

This study was approved by the regional ethical committees of Aarhus (M-20080178) and the Danish Data Protection Agency (2008-54-0558).

Conflict of interest

None declared

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. K. Larsen.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplement 1

Primer sequences, location of the primers with respect to the exon/intron boundaries as well as conditions for thermal cycling used to generate PCR products for DNA sequencing of the translated exon RYR2. Unless otherwise indicated, the 5′ primer is used as sequencing primer (DOC 98 kb)

Supplement 2

Primer and probe sequences for RYR2 SNP PCR assays (DOC 38.5 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Larsen, M.K., Berge, K.E., Leren, T.P. et al. Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases. Int J Legal Med 127, 139–144 (2013). https://doi.org/10.1007/s00414-011-0658-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00414-011-0658-2

Keywords

Navigation